CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 91 filers reported holding CUREVAC N V in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $223,551 | +251080.9% | 21,454 | +45.3% | 0.00% | +50.0% |
Q4 2022 | $89 | -100.0% | 14,762 | -33.9% | 0.00% | -75.0% |
Q2 2022 | $304,000 | +22.1% | 22,335 | +75.8% | 0.01% | +33.3% |
Q1 2022 | $249,000 | -21.9% | 12,707 | +36.5% | 0.01% | +20.0% |
Q4 2021 | $319,000 | +46.3% | 9,307 | +213.2% | 0.01% | +25.0% |
Q2 2021 | $218,000 | -21.3% | 2,972 | -1.9% | 0.00% | -33.3% |
Q1 2021 | $277,000 | – | 3,031 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,625,943 | $11,332,823 | 10.01% |
RA Capital Management | 12,245,955 | $85,354,306 | 1.93% |
Avidity Partners Management LP | 3,550,000 | $24,743,500 | 0.82% |
Camber Capital Management LP | 1,250,000 | $8,713 | 0.27% |
Ghisallo Capital Management LLC | 100,000 | $697,000 | 0.17% |
FOX RUN MANAGEMENT, L.L.C. | 31,278 | $218,008 | 0.07% |
Alyeska Investment Group, L.P. | 1,060,382 | $7,390,863 | 0.06% |
Green Alpha Advisors, LLC | 12,351 | $86,086 | 0.06% |
Virtus ETF Advisers LLC | 14,114 | $98,375 | 0.05% |
Quantamental Technologies LLC | 11,146 | $77,688 | 0.04% |